Cannabis Laws in Portugal

Decriminalization, Lisbon Cannabis Scene & Medical Program – Your Complete 2026 Legal Guide

🇵🇹 Key Findings: Portugal Cannabis Law 2026

Personal Possession (up to 25g herb / 5g resin) Decriminalized – Administrative Only
Cannabis Sales Illegal – Criminal Offence
Medical Cannabis Legal Since 2018 – Prescription Required
Criminal Record for Possession No – CDT Process Only
Tourist Practical Risk Low for Personal Amounts – No Legal Purchase

Legal Status at a Glance

Category Status Details
Possession (up to 25g herb) Decriminalized Administrative sanction only; CDT hearing; no criminal record; fine or treatment referral
Possession (above 25g) Criminal Offence Above threshold triggers supply presumption; prosecution under drugs law; prison sentence possible
Hash/Resin (up to 5g) Decriminalized Same administrative process as herb; separate threshold for resin preparations
Sales / Trafficking Illegal Law 15/93 and Criminal Code; 4 to 12 years imprisonment; actively prosecuted
Medical Cannabis Legal Law 33/2018; prescription from licensed physicians; dispensed through authorized pharmacies
CBD Products Legal Below 0.2% THC; widely sold in specialized shops and pharmacies across Portugal
Driving Under Influence Criminal Offence Road Traffic Code Article 81; any detectable THC; fine, license suspension, possible prison

Current Legal Framework

Portugal's Law 30/2000 is one of the most studied and cited pieces of drug legislation in the world. Enacted in November 2000 and taking effect July 1, 2001, it decriminalized personal possession of all psychoactive substances — not just cannabis — below a 10-day supply threshold. For cannabis herb (marijuana), this threshold was set at 25 grams; for cannabis resin (hashish), at 5 grams. These thresholds represent presumed personal use quantities — above them, the presumption shifts toward trafficking intent and criminal prosecution resumes under the underlying Decree-Law 15/93. The law was designed not to "legalize" drugs but to shift the state's response to personal drug use from criminal punishment to public health intervention.

The mechanism created by Law 30/2000 is the Dissuasion Commission (Comissão para a Dissuasão da Toxicodependência, CDT). When police encounter a person possessing drugs below threshold amounts, they do not arrest them but refer them to their district's CDT within 72 hours. The CDT is a three-person panel typically comprising a lawyer, a social worker, and a medical professional. The CDT hearing assesses whether the individual is a user or problematic user and can impose administrative sanctions: fines of 25 to 150 EUR for first offenders (or for those not classified as dependent users), suspension of professional licenses, prohibition from frequenting certain locations, or required attendance at treatment or harm reduction programs. The CDT can also suspend sanctions for users who voluntarily enter treatment. No criminal record results from CDT proceedings — this is the fundamental difference between decriminalization and the prior criminal approach.

Portugal decriminalization law does not authorize sales, supply, or cultivation. The trafficking framework under Decree-Law 15/93 remains fully operative — dealing cannabis carries 4 to 12 years imprisonment depending on quantity and organization. Portuguese police and prosecutors actively pursue trafficking networks, and Portugal position as a major transit country for Moroccan cannabis (through the southern Alentejo region and Algarve coastline, and the Port of Setúbal) means large-scale trafficking enforcement is a significant activity. The combination of personal decriminalization with maintained trafficking prohibition reflects a deliberate "both-and" strategy: protect personal users from criminalization while maintaining serious penalties for the commercial supply chain.

In 2018, Portugal took a further step with Law 33/2018 (Law on Access to Cannabis-Based Medicines), which authorized the prescription, dispensing, and use of cannabis-based medicines for therapeutic purposes. The Infarmed authority (National Authority of Medicines and Health Products) was given regulatory oversight of the medical cannabis supply chain. By 2020, Portugal had also authorized industrial hemp cultivation under EU regulations and, by 2022, had licensed several cannabis production facilities for pharmaceutical-grade export, positioning the country as a significant European licensed cannabis producer. Portuguese-grown medical cannabis is exported to Germany, the UK, and other European markets.

Penalties and Enforcement

Offense Quantity Penalty Enforcement Reality
Personal Possession (Herb) Up to 25g CDT hearing; fine 25–150 EUR Police refer to CDT; no arrest; CDT often suspends sanctions for first-timers; no criminal record
Personal Possession (Resin) Up to 5g CDT hearing; same sanctions Same administrative process; foreigners referred to CDT like nationals
Possession Above Threshold Above 25g herb Criminal prosecution (DL 15/93) Supply presumption; prosecution follows; judges have discretion on sentences; bail usually possible
Trafficking / Sales Any supply 4–12 years prison Actively prosecuted by Policia Judiciária; undercover operations in Lisbon and Porto neighborhoods
Large Scale Trafficking Organized / large quantity 12–25 years (aggravated) International trafficking via Portugal; Moroccan hash transit route; Europol cooperation
Driving Under Influence Any detectable THC Fine + license suspension; possible prison Active enforcement; oral fluid testing at checkpoints; zero tolerance policy; separate from possession rules

Medical Cannabis Program

Portugal's Law 33/2018 (Autoriza o uso de medicamentos à base de Cannabis para fins medicinais) authorized the prescription and use of cannabis-based medicines in June 2018. Under the framework, licensed physicians can prescribe cannabis-based products for patients who have not responded adequately to conventional treatments for approved conditions including chronic pain, multiple sclerosis spasticity, chemotherapy-related nausea and vomiting, and treatment-resistant epilepsy. The Infarmed authority oversees authorization of cannabis medicines, prescriber licensing, and pharmacy dispensing compliance.

Initial program implementation was slow due to regulatory complexity and the limited number of authorized cannabis-based medicines available in Portugal's pharmacy system. By 2022, the program had expanded with the authorization of imported cannabis flower products from licensed Canadian and Dutch producers in addition to Sativex and Epidyolex. The 2022 expansion of Portugal's licensed domestic cannabis production sector — with several INFARMED-licensed cultivation facilities operating in Alentejo, Ribatejo, and near Lisbon — began supplying the domestic medical market, reducing import dependency and costs. By 2025, approximately 15,000 to 20,000 patients had received medical cannabis prescriptions through the program, primarily for pain and neurological conditions.

Portugal has become a notable European licensed cannabis producer, with cultivation operations taking advantage of the country's favorable climate, low land costs, and EU membership providing regulatory alignment with European pharmaceutical standards. Licensed producers include Portuguese companies and subsidiaries of international cannabis companies. The export market — primarily serving German, UK, and Swiss pharmaceutical importers — generates significant revenue and has attracted substantial investment. Several of Portugal's largest cannabis producers have successfully obtained GMP (Good Manufacturing Practice) certification from INFARMED, enabling pharmaceutical-grade export. This positions Portugal as one of Europe's most significant licensed cannabis production jurisdictions alongside the Netherlands and Denmark.

Industry and Market Data

Portugal cannabis sector encompasses both an illicit consumer market, a legal CBD industry, a medical cannabis production sector, and an export-oriented licensed cultivation industry. The illicit recreational market is estimated to serve approximately 400,000 to 600,000 regular cannabis users in Portugal (approximately 4 to 6 percent of the adult population), with annual market value estimated at 500 to 700 million EUR based on consumer survey data and price estimates. Cannabis is typically imported — Moroccan hash remains dominant in Portugal's market given geographic proximity and established trafficking routes along the Alentejo and Algarve coastlines.

The licensed pharmaceutical cannabis export industry has grown rapidly since 2019. By 2025, Portugal had over 20 licensed cannabis cultivation and processing operations, with combined licensed production capacity exceeding 100 tonnes annually. The major licensed producers include Tilray Portugal (Tilray's European cultivation hub), MGC Pharmaceuticals' Portuguese operation, and several domestic companies including Flora Lab and Purafarma. Portugal's production cost advantages — lower labor and land costs than Northern European producers — combined with its EU regulatory standing make it competitive in European pharmaceutical cannabis supply chains.

The CBD retail market in Portugal has expanded significantly since 2019, with specialized shops in Lisbon (particularly in the Mouraria, Bairro Alto, and Chiado areas), Porto, and resort towns of the Algarve. CBD flowers, oils, edibles, and topicals are sold legally under the 0.2% THC threshold. The CBD market contributes to cannabis tourism indirectly by providing a legal, visible cannabis retail scene that normalizes the broader cannabis culture for visiting tourists. Portuguese CBD retailers also serve as information sources for tourists seeking to understand local cannabis norms.

Cannabis Culture and History

Portugal cannabis culture is inseparable from its history as a transit country for Moroccan cannabis and its experience with the heroin crisis of the 1980s and 1990s. Cannabis has been present in Portuguese society since at least the colonial period, with hemp fiber cultivation traditional in the Minho and Douro regions. The explosion of cannabis use in Portugal during the 1970s and 1980s reflected European trends and the country's opening after the Carnation Revolution of 1974, which ended the Salazar-Caetano dictatorship. The simultaneous rise of heroin addiction in Lisbon's peripheral neighborhoods and the total failure of criminal prohibition to contain it became the public health crisis that ultimately drove the 2001 decriminalization law.

Lisbon's cannabis culture is concentrated in the historic neighborhoods of Bairro Alto (known for nightlife), Mouraria (the old Moorish quarter), and increasingly in the Intendente and Martim Moniz areas. The city's cannabis scene is notably less visible than Amsterdam or Barcelona's — there are no coffee shops, no sign-posted cannabis outlets, and no "cannabis tourism" industry comparable to those cities. Instead, cannabis use is woven into Lisbon's broader social fabric: present in house parties, outdoor social gatherings at miradouros (viewpoints), and in some bars. The Alfama neighborhood's fado culture intersects with a more discreet cannabis tradition. Lisbon's cannabis users benefit from the CDT system's protection against arrest, creating a relatively relaxed personal use culture.

The impact of Portugal decriminalization on public health has been the subject of intense international study. The empirical evidence accumulated over 20+ years consistently shows that decriminalization did not increase cannabis or drug use rates among Portuguese youth, while HIV infections among drug users fell dramatically, drug-related deaths declined, and treatment program uptake increased significantly. Portugal's model is cited in policy debates in virtually every country considering drug reform. This international reputation as a drug policy success story has become part of Portugal's national identity and is acknowledged across the political spectrum, though the conservative parties have historically been ambivalent about publicly celebrating the policy's origins under a Socialist government.

Traveler Guide

ℹ️ Practical Information for Visitors

Portugal is one of the most relaxed cannabis environments in Europe for tourists. Possession of personal amounts results in administrative proceedings rather than arrest or criminal charges. There is no legal purchase channel, but the CDT system means tourists won't face prison for personal use. Lisbon and Porto are genuine cannabis-friendly destinations — be discreet, keep amounts minimal, and avoid any commercial activity.

Do's

Don'ts

MW
Marcus Webb
Medical Cannabis Writer

Health & Science writer with nursing background, specializing in medical cannabis research.

Medical Cannabis • Drug Testing • Health Research • Dosing

Frequently Asked Questions

Is cannabis legal in Portugal?

Cannabis is not fully legal but has been decriminalized since 2001 under Law 30/2000. Possession of up to 25 grams is an administrative violation with no criminal record. Trafficking and sales remain criminal offences. Medical cannabis has been legal since 2018 under Law 33/2018.

What is Portugal drug decriminalization law?

Law 30/2000 (effective July 2001) decriminalized personal possession of all drugs below 10-day supply thresholds. For cannabis, that means up to 25g herb or 5g resin. Cases go to Dissuasion Commissions (CDTs) which impose administrative sanctions but no criminal penalties. The law was designed as a public health measure, prioritizing treatment over punishment.

How much cannabis can you have in Portugal without criminal charge?

Up to 25 grams of cannabis herb or 5 grams of cannabis resin (hashish) is treated as personal use and handled through the CDT administrative process — no criminal charge, no arrest. Above these thresholds, supply intent is presumed and criminal prosecution applies under Decree-Law 15/93.

Is there legal cannabis for tourists in Lisbon?

There is no legal cannabis retail in Portugal — sales remain a criminal offence. Lisbon has a visible cannabis culture and CBD shops operate legally. Decriminalization means tourists carrying personal amounts face only CDT administrative proceedings, not arrest. The Bairro Alto, Mouraria, and riverside areas have the most relaxed enforcement environments.

Does Portugal have a medical cannabis program?

Yes. Law 33/2018 legalized medical cannabis for conditions including chronic pain, MS spasticity, and epilepsy. Physicians prescribe through licensed pharmacies overseen by Infarmed. Portugal has also become a significant licensed cannabis producer for European pharmaceutical markets, with GMP-certified facilities exporting to Germany, the UK, and Switzerland.

Share: